MET‐Activating Ubiquitin Multimers
Open Access
- 31 July 2023
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 62 (36) , e202307157
Abstract
Receptor tyrosine kinases (RTKs) are generally activated through their dimerization and/or oligomerization induced by their cognate ligands, and one such RTK hepatocyte growth factor (HGF) receptor, known as MET, plays an important role in tissue regeneration. Here we show the development of ubiquitin (Ub)‐based protein ligand multimers, referred to as U‐bodies, which act as surrogate agonists for MET and are derived from MET‐binding macrocyclic peptides. Monomeric Ub constructs (U‐body) were first generated by genetic implantation of a macrocyclic peptide pharmacophore into a structural loop of Ub (lasso‐grafting) and subsequent optimization of its flanking spacer sequences via mRNA display. Such U‐body constructs exhibit potent binding affinity to MET, thermal stability, and proteolytic stability. The U‐body constructs also partially/fully inhibited or enhanced HGF‐induced MET‐phosphorylation. Their multimerization to dimeric, tetrameric, and octameric U‐bodies linked by an appropriate peptide linker yielded potent MET activation activity and downstream cell proliferation‐promoting activity. This work suggests that lasso‐grafting of macrocycles to Ub is an effective approach to devising protein‐based artificial RTK agonists and it can be useful in the development of a new class of biologics for various therapeutic applications.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP21J11472, JP21K15482, JP21K18250, JP20H05618)
- Japan Agency for Medical Research and Development (JP21cm0106201, JP23ama221402)
- Cancer Research Institute, Kanazawa University
This publication has 38 references indexed in Scilit:
- Conformational stabilization of ubiquitin yields potent and selective inhibitors of USP7Nature Chemical Biology, 2012
- New Binding Mode to TNF-Alpha Revealed by Ubiquitin-Based Artificial Binding ProteinPLOS ONE, 2012
- Structural insights into Met receptor activationEuropean Journal of Cell Biology, 2011
- Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonistsProceedings of the National Academy of Sciences, 2011
- MET signalling: principles and functions in development, organ regeneration and cancerNature Reviews Molecular Cell Biology, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Hepatocyte Growth Factor Enhances MMP Activity in Human Endothelial CellsBiochemical and Biophysical Research Communications, 2000
- Molecular evolution and domain structure of plasminogen‐related growth factors (HGF/SF and HGF1/MSP)Protein Science, 1994
- Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene ProductScience, 1991
- Molecular cloning and expression of human hepatocyte growth factorNature, 1989